HCPCS Level II drug code
J3260 — Injection, tobramycin sulfate, up to 80 mg
In short
J3260 is the HCPCS Level II code for injection, tobramycin sulfate, up to 80 mg. CMS assigns NDCs for Tobramycin and Tobramycin Sulfate to it. The Medicare Part B payment limit is $2.345 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, tobramycin sulfate, up to 80 mg
- Short descriptor
- Tobramycin sulfate injection
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 1997
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J3260
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 19 NDCs to J3260 for Tobramycin and Tobramycin Sulfate. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Tobramycin | 70700-0173-22 | Xiromed, LLC | 1 | 15 |
| Tobramycin Sulfate | 00409-3578-01 | Pfizer Inc | 25 × 2 | 25 |
| Tobramycin Sulfate | 36000-0242-01 | Baxter Healthcare Corporation | 1 | 15 |
| Tobramycin Sulfate | 36000-0244-25 | Baxter Healthcare Corporation | 25 × 2 | 25 |
| Tobramycin Sulfate | 39822-0412-01 | XGen Pharmaceuticals DJB, Inc. | 1 | 15 |
| Tobramycin Sulfate | 39822-0412-06 | XGen Pharmaceuticals DJB, Inc. | 6 × 1 | 90 |
| Tobramycin Sulfate | 55150-0470-06 | Eugia US LLC | 6 × 1 | 90 |
| Tobramycin Sulfate | 63323-0303-51 | FreseniUS Kabi USA, LLC | 6 × 1 | 90 |
| Tobramycin Sulfate | 63323-0303-55 | FreseniUS Kabi USA, LLC | 6 × 1 | 90 |
| Tobramycin Sulfate | 63323-0305-02 | FreseniUS Kabi USA, LLC | 25 × 2 | 7 |
| Tobramycin Sulfate | 63323-0306-02 | FreseniUS Kabi USA, LLC | 25 × 2 | 25 |
| Tobramycin Sulfate | 63323-0306-30 | FreseniUS Kabi USA, LLC | 10 × 30 | 150 |
| Tobramycin Sulfate | 67457-0428-30 | Mylan Institutional LLC | 10 × 30 | 150 |
| Tobramycin Sulfate | 67457-0473-22 | Mylan Institutional LLC | 25 × 2 | 25 |
| Tobramycin Sulfate | 70436-0110-56 | Slate Run Pharmaceuticals | 6 × 1 | 90 |
| Tobramycin Sulfate | 70436-0110-80 | Slate Run Pharmaceuticals | 1 | 15 |
| Tobramycin Sulfate | 70700-0173-86 | Xiromed, LLC | 6 × 1 | 90 |
| Tobramycin Sulfate | 72266-0163-06 | Fosun Pharma USA Inc. | 6 × 1 | 90 |
| Tobramycin Sulfate | 72603-0160-06 | Northstar RxLLC | 6 × 1 | 90 |
J3260: common questions
- Is J3260 a CPT code?
- No. J3260 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J3260?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 19 NDCs under J3260, for Tobramycin and Tobramycin Sulfate. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J3260?
- $2.345 per 80 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.